These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 26477665)

  • 1. Metabolic Acidosis of CKD: An Update.
    Kraut JA; Madias NE
    Am J Kidney Dis; 2016 Feb; 67(2):307-17. PubMed ID: 26477665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse Effects of the Metabolic Acidosis of Chronic Kidney Disease.
    Kraut JA; Madias NE
    Adv Chronic Kidney Dis; 2017 Sep; 24(5):289-297. PubMed ID: 29031355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does correction of metabolic acidosis slow chronic kidney disease progression?
    Goraya N; Wesson DE
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):193-7. PubMed ID: 23380803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate.
    Goraya N; Simoni J; Jo CH; Wesson DE
    Kidney Int; 2014 Nov; 86(5):1031-8. PubMed ID: 24694986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance to Sodium in Patients With CKD-Induced Metabolic Acidosis: Does the Accompanying Anion Matter?
    Bushinsky DA
    Am J Kidney Dis; 2019 Jun; 73(6):858-865. PubMed ID: 30518477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic acidosis is common and associates with disease progression in children with chronic kidney disease.
    Harambat J; Kunzmann K; Azukaitis K; Bayazit AK; Canpolat N; Doyon A; Duzova A; Niemirska A; Sözeri B; Thurn-Valsassina D; Anarat A; Bessenay L; Candan C; Peco-Antic A; Yilmaz A; Tschumi S; Testa S; Jankauskiene A; Erdogan H; Rosales A; Alpay H; Lugani F; Arbeiter K; Mencarelli F; Kiyak A; Dönmez O; Drozdz D; Melk A; Querfeld U; Schaefer F;
    Kidney Int; 2017 Dec; 92(6):1507-1514. PubMed ID: 28729033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD.
    Bushinsky DA; Hostetter T; Klaerner G; Stasiv Y; Lockey C; McNulty S; Lee A; Parsell D; Mathur V; Li E; Buysse J; Alpern R
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):26-35. PubMed ID: 29102959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment.
    Kraut JA; Kurtz I
    Am J Kidney Dis; 2005 Jun; 45(6):978-93. PubMed ID: 15957126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of metabolic acidosis in patients with chronic kidney disease (CKD)].
    Dębowska M; Przedlacki J
    Wiad Lek; 2017; 70(6 pt 2):1197-1200. PubMed ID: 29533913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine citrate excretion as a marker of acid retention in patients with chronic kidney disease without overt metabolic acidosis.
    Goraya N; Simoni J; Sager LN; Madias NE; Wesson DE
    Kidney Int; 2019 May; 95(5):1190-1196. PubMed ID: 30846270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Metformin Use and the Associated Risk of Metabolic Acidosis in US Diabetic Adults With CKD: A National Cross-Sectional Study.
    Kuo CC; Yeh HC; Chen B; Tsai CW; Lin YS; Huang CC
    Medicine (Baltimore); 2015 Dec; 94(51):e2175. PubMed ID: 26705203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study).
    Gaggl M; Cejka D; Plischke M; Heinze G; Fraunschiel M; Schmidt A; Hörl WH; Sunder-Plassmann G
    Trials; 2013 Jul; 14():196. PubMed ID: 23826760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperchloremic acidosis develops at the stage G4 and shifts to high anion gap acidosis at the stage G5 in chronic kidney disease.
    Tanemoto M; Kamachi R; Kimura T; Yamada S; Yokoyama T; Okazaki Y
    Clin Exp Nephrol; 2020 Dec; 24(12):1140-1143. PubMed ID: 32772208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid-base status and progression of chronic kidney disease.
    Goraya N; Wesson DE
    Curr Opin Nephrol Hypertens; 2012 Sep; 21(5):552-6. PubMed ID: 22874469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperchloremic normal gap metabolic acidosis.
    Palmer BF; Clegg DJ
    Minerva Endocrinol; 2019 Dec; 44(4):363-377. PubMed ID: 31347344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Bicarbonate on Net Acid Excretion, Blood Pressure, and Metabolism in Patients With and Without CKD: The Acid Base Compensation in CKD Study.
    Tyson CC; Luciano A; Modliszewski JL; Corcoran DL; Bain JR; Muehlbauer M; Ilkayeva O; Pourafshar S; Allen J; Bowman C; Gung J; Asplin JR; Pendergast J; Svetkey LP; Lin PH; Scialla JJ
    Am J Kidney Dis; 2021 Jul; 78(1):38-47. PubMed ID: 33810868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Acid-Base Balance in Chronic Kidney Disease.
    Nagami GT; Hamm LL
    Adv Chronic Kidney Dis; 2017 Sep; 24(5):274-279. PubMed ID: 29031353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of metabolic acidosis to ameliorate wasting in chronic kidney disease: goals and strategies.
    Chiu YW; Kopple JD; Mehrotra R
    Semin Nephrol; 2009 Jan; 29(1):67-74. PubMed ID: 19121476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Serum Bicarbonate and CKD Progression in Children.
    Brown DD; Roem J; Ng DK; Reidy KJ; Kumar J; Abramowitz MK; Mak RH; Furth SL; Schwartz GJ; Warady BA; Kaskel FJ; Melamed ML
    Clin J Am Soc Nephrol; 2020 Jun; 15(6):755-765. PubMed ID: 32467307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.